Document Type
Article
Publication Date
2012
Abstract
This drug information question and answer sheet discusses the use of apixaban (Eliquis) for the primary prevention of stroke in patients with atrial fibrillation.
Recommended Citation
Dang J, Tsu LV. What evidence is available on apixaban for the primary prevention of stroke in patients with atrial fibrillation? Arizona Journal of Pharmacy 2012;4:30-1.
Copyright
Arizona Journal of Pharmacy. All rights reserved. This publication may not be republished or re-distributed without authorization from the Arizona Pharmacy Association.
Included in
Cardiovascular Diseases Commons, Medical Education Commons, Other Pharmacy and Pharmaceutical Sciences Commons, Science and Mathematics Education Commons
Comments
This article was originally published in Arizona Journal of Pharmacy, volume 4, in 2012. Those receiving articles through Chapman University Digital Commons may not receive Continuing Education (CE) credit.